EicOsis Human Health, Inc.
PrivateLast Round
Grant
Jan 1, 2025
Total Funding Raised
$21.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EicOsis Human Health, Inc. is a biopharmaceutical company developing non-narcotic oral analgesics that inhibit the soluble epoxide hydrolase (sEH) enzyme to treat neuropathic and inflammatory pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EicOsis Human Health, Inc. Comparables
Compare EicOsis Human Health, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| South Rampart Pharma, Inc. | 82% | |
| Algiax Pharmaceuticals | 80% | |
| Regulonix | 79% |
EicOsis Human Health, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2025 | ||||
| Grant | Oct 30, 2019 | ||||
| Grant | Oct 15, 2019 | ||||
| VC Round | Mar 19, 2019 | ||||
| Grant | Jan 8, 2016 |
EicOsis Human Health, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute on Drug Abuse | Grant |
| Coefficient Giving | VC Round |
| NIH Helping to End Addiction Long-term (HEAL) Initiative | Grant |
| NIH RADx | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 118% MoM.
- Jun 1, 2025
Monthly visitors increased 101% MoM, reaching 600.
EicOsis Human Health, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EicOsis Human Health, Inc.'s valuation, stock price, and market status.
Is EicOsis Human Health, Inc. a public or private company?
EicOsis Human Health, Inc. is a private company.
What is the current stock price of EicOsis Human Health, Inc.?
EicOsis Human Health, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is EicOsis Human Health, Inc. worth (valuation)?
Valuation information for EicOsis Human Health, Inc. is not publicly available.
Can I buy EicOsis Human Health, Inc. stock?
EicOsis Human Health, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EicOsis Human Health, Inc.'s last funding round?
EicOsis Human Health, Inc.'s most recent funding round was Grant on January 1, 2025.
Who are the main investors in EicOsis Human Health, Inc.?
Key investors in EicOsis Human Health, Inc. include Coefficient Giving.
Will EicOsis Human Health, Inc. IPO soon?
No public IPO plans have been announced for EicOsis Human Health, Inc..
How can I track EicOsis Human Health, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EicOsis Human Health, Inc.'s secondary market activity and sign up for updates.